Osteonecrosis of the jaw associated with bisphosphonate therapy.
Wirth
Scott M
SM
UPMC Cancer Centers, University of Pittsburgh Medical Center; Pittsburgh, Pennsylvania, USA. wirths@upmc.edu
Lawson
Amber P
AP
Sutphin
Stephanie D
SD
Adams
Val R
VR
D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D004164:Diphosphonates / Q000009:adverse effects*; D006801:Humans; D007568:Jaw / Q000187:drug effects* / Q000473:pathology; D007571:Jaw Diseases / Q000139:chemically induced* / Q000473:pathology; D010020:Osteonecrosis / Q000139:chemically induced* / Q000473:pathology; D012307:Risk Factors
D050071:Bone Density Conservation Agents; D004164:Diphosphonates